Search Results 21-30 of 16280 for Chronic Lymphocytic Leukemia
... chronic lymphocytic leukemia (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
A Study Evaluating the Safety and Effectiveness of JCAR017 to Treat Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL).
Clinical Trials · A Study of Hematopoiesis in Patients with Monoclonal B Cell Lymphocytosis (MBL), B-Chronic Lymphocytic Leukemia (CLL), and Healthy Controls.
A Study of APG-2575 Alone or in Combination with Other Therapeutic Agents to Treat Relapsed and/or Refractory Chronic Lymphocytic Leukemia (CLL)/Small ...
... chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Participation eligibility. Participant eligibility includes age, gender, type and stage of ...
Here's what she wants families to know about this disease: 1. ALL is rare and has a collection of persistent symptoms. In 2023, the American Cancer Society ...
Dr. Cerhan's NHL & CLL case-control study at Mayo Clinic tests hypotheses about the etiology of non-Hodgkin lymphoma and chronic lymphocytic leukemia.
- Diagnosis of: - Biopsy-proven small lymphocytic lymphoma (SLL) , or - Diagnosis of chronic lymphocytic leukemia (CLL) with a clonal B-cell population in ...
Mayo Clinic offers patients diagnosed with chronic lymphocytic leukemia (CLL) nonstandard, specialized testing — tools to help them understand their ...
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Their crucial work saves lives every day. Let Mayo Clinic researchers know they’re appreciated with a quick message.